Literature DB >> 16724341

Interleukin-1alpha stimulates non-amyloidogenic pathway by alpha-secretase (ADAM-10 and ADAM-17) cleavage of APP in human astrocytic cells involving p38 MAP kinase.

Sanghamitra Bandyopadhyay1, Dean M Hartley, Catherine M Cahill, Debomay K Lahiri, Naibedya Chattopadhyay, Jack T Rogers.   

Abstract

Interleukin-1alpha (IL-1alpha) stimulates a disintegrin and metalloproteinase, ADAM-17 synthesis, consistent with activation of the soluble fragment of Amyloid Precursor Protein, APP, (sAPPalpha) in human primary astrocytes. To characterize the mechanism by which IL-1alpha promotes the non-amyloidogenic pathway of APP metabolism, we used U373 MG astrocytoma cells. IL-1alpha significantly increased levels of ADAM-10 and ADAM-17 mRNA in 16 hr. Upregulation of ADAM-17 mRNA by IL-1alpha was more pronounced despite higher basal levels of ADAM-10 mRNA. This pattern was also observed at the protein level with the upregulation of alpha-secretase. RNA interference (RNAi) of ADAM-10 and ADAM-17 inhibited IL-1alpha-stimulated sAPPalpha release and the effect was more pronounced with ADAM-17 RNAi. Concomitantly, the level of sAPPalpha was significantly increased by IL-1alpha in 48 hr; however, IL-1alpha stimulated cell-associated APP levels maximally at 6 h but the induction declined at 48 hr. IL-1alpha treatment of cells for 48 h reduced both intracellular and secreted levels of amyloid-beta, Abeta-40, and Abeta-42 peptides. Multiple MAP kinases (MAPK), including MEK/ERK, p38 kinase, PI3 kinase (PI3K) but not JNK were involved in the regulation of IL-1alpha-stimulated alpha-secretase activity and sAPPalpha release. p38 MAPK seems to be the most proximal of these MAPKs, as it was the earliest to be activated by IL-1alpha and blocking this pathway attenuated activation of IL-1alpha-induced MEK and PI3K pathways. Our data show a complex mechanism of sAPPalpha regulation by IL-1alpha that involves ADAM-10, ADAM-17 and p38 MAPK upstream of MEK and PI3K. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724341     DOI: 10.1002/jnr.20864

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

Review 1.  Obesity, leptin, and Alzheimer's disease.

Authors:  Edward B Lee
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

2.  Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.

Authors:  Zhiyou Cai; Zhou Liu; Ming Xiao; Chuanling Wang; Fuming Tian
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

Review 3.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

Review 4.  The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease.

Authors:  Meng Qian; Xiaoqiang Shen; Huanhuan Wang
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

5.  An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Authors:  Oskar Adolfsson; Maria Pihlgren; Nicolas Toni; Yvan Varisco; Anna Lucia Buccarello; Katia Antoniello; Sophie Lohmann; Kasia Piorkowska; Valerie Gafner; Jasvinder K Atwal; Janice Maloney; Mark Chen; Alvin Gogineni; Robby M Weimer; Deborah L Mortensen; Michel Friesenhahn; Carole Ho; Robert Paul; Andrea Pfeifer; Andreas Muhs; Ryan J Watts
Journal:  J Neurosci       Date:  2012-07-11       Impact factor: 6.167

6.  MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury.

Authors:  Kelly M Warren; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2012-05-14       Impact factor: 5.269

Review 7.  Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.

Authors:  Sanghamitra Bandyopadhyay; Jack T Rogers
Journal:  Biochem Pharmacol       Date:  2014-02-07       Impact factor: 5.858

Review 8.  Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization.

Authors:  Caroline A Owen
Journal:  Int J Biochem Cell Biol       Date:  2008-01-31       Impact factor: 5.085

Review 9.  Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.

Authors:  Jack T Rogers; Ashley I Bush; Hyan-Hee Cho; Deborah H Smith; Andrew M Thomson; Avi L Friedlich; Debomoy K Lahiri; Peter J Leedman; Xudong Huang; Catherine M Cahill
Journal:  Biochem Soc Trans       Date:  2008-12       Impact factor: 5.407

Review 10.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.